Sale looms as Chinese develop a thirst for Accolade Wines

Accolade Wines is set to appoint investment banks for a dual-track process within the next month, according to sources, as the company becomes the latest target of Chinese conglomerates in search of opportunities in the Australian food and healthcare space. Suitors from China for some months have been courting the private equity-owned operation that counts Hardys as among its brands, as first reported by this column.